Neurostimulation Devices Market Trends 2015 and Forecast by 2019: MarketResearchReports.Biz
Available pharmacological treatment for conditions such as chronic pain, epilepsy, Parkinson's disease, and depression are not sufficient for all patients at all stages of treatment. More than 100 million people suffer from these conditions in the US alone. Though drug therapy, physiotherapy, and surgeries are effective treatment options, they are not suitable for all patients. For example, approximately 15-20% of epilepsy patients are drug-resistant and require alternate treatment method. Neurostimulation is a potential alternative for patients for whom the drug...
View full press release